Compare IART & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | OPY |
|---|---|---|
| Founded | 1989 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1996 | 1996 |
| Metric | IART | OPY |
|---|---|---|
| Price | $13.20 | $121.41 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $18.38 | N/A |
| AVG Volume (30 Days) | ★ 844.5K | 92.5K |
| Earning Date | 10-29-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ 104.71 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $1,638,071,000.00 |
| Revenue This Year | $1.83 | N/A |
| Revenue Next Year | $3.36 | N/A |
| P/E Ratio | ★ N/A | $202.45 |
| Revenue Growth | N/A | ★ 14.35 |
| 52 Week Low | $8.70 | $63.81 |
| 52 Week High | $20.49 | $125.88 |
| Indicator | IART | OPY |
|---|---|---|
| Relative Strength Index (RSI) | 27.98 | 56.62 |
| Support Level | $10.42 | $103.03 |
| Resistance Level | $14.12 | $124.56 |
| Average True Range (ATR) | 0.68 | 4.91 |
| MACD | -0.18 | 0.24 |
| Stochastic Oscillator | 19.25 | 73.96 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.